New pill could tame Hormone-Driven high blood pressure
NCT ID NCT07550465
First seen Apr 27, 2026 · Last updated May 16, 2026 · Updated 2 times
Summary
This study tests a new tablet called QLS1410 for people with primary aldosteronism, a condition where the body makes too much of a hormone that raises blood pressure. About 60 adults will receive either the study drug or a placebo daily for up to 12 weeks. The main goal is to see if the drug safely lowers blood pressure better than a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY ALDOSTERONISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.